Kaiwei Xu

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yuchao Zhu · 4 shared papers, 2022–2024 · strength 0.73
   • Paper Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic c… DOI 10.7150/thno.89805↗
   • Paper Black TiO2-based nanoparticles as Toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy… DOI 10.1186/s12645-024-00266-2↗
   • Paper USIO as an imaging nanoenzyme loaded autologous exosomes for targeted imaging and chemotherapy promotion of pancreatic … DOI 10.21203/rs.3.rs-3383746/v1↗
2. Lufei Jin · 4 shared papers, 2022–2024 · strength 0.72
   • Paper VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancrea… DOI 10.1016/j.mtbio.2024.101106↗
   • Paper Black TiO2-based nanoparticles as Toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy… DOI 10.1186/s12645-024-00266-2↗
   • Paper USIO as an imaging nanoenzyme loaded autologous exosomes for targeted imaging and chemotherapy promotion of pancreatic … DOI 10.21203/rs.3.rs-3383746/v1↗
3. Hong Lu · 3 shared papers, 2021–2024 · strength 0.51
   • Paper Black TiO2-based nanoparticles as Toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy… DOI 10.1186/s12645-024-00266-2↗
   • Paper Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer. DOI 10.1002/jcla.24447↗
   • Paper Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer. DOI 10.2217/bmm-2020-0750↗
4. Lubing Zhu · 2 shared papers, 2024 · strength 0.40
   • Paper The prognostic value of VISTA combined with imaging in pancreatic cancer patients DOI 10.21203/rs.3.rs-3855646/v1↗
   • Paper VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancrea… DOI 10.1016/j.mtbio.2024.101106↗
5. Jianhua Wang · 2 shared papers, 2024 · strength 0.38
   • Paper VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancrea… DOI 10.1016/j.mtbio.2024.101106↗
   • Paper Black TiO2-based nanoparticles as Toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy… DOI 10.1186/s12645-024-00266-2↗
6. Jianhua Wang · 2 shared papers, 2023–2024 · strength 0.37
   • Paper Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic c… DOI 10.7150/thno.89805↗
   • Paper USIO as an imaging nanoenzyme loaded autologous exosomes for targeted imaging and chemotherapy promotion of pancreatic … DOI 10.21203/rs.3.rs-3383746/v1↗
7. Jianhua Wang · 2 shared papers, 2021–2022 · strength 0.32
   • Paper Exosomal circular RNA hsa_circ_0006220, and hsa_circ_0001666 as biomarkers in the diagnosis of pancreatic cancer. DOI 10.1002/jcla.24447↗
   • Paper Increased levels of circulating circular RNA (hsa_circ_0013587) may serve as a novel biomarker for pancreatic cancer. DOI 10.2217/bmm-2020-0750↗
8. Jianhua Wang · 1 shared paper, 2024 · strength 0.21
   • Paper The prognostic value of VISTA combined with imaging in pancreatic cancer patients DOI 10.21203/rs.3.rs-3855646/v1↗
9. Lu Hong · 1 shared paper, 2024 · strength 0.19
   • Paper VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancrea… DOI 10.1016/j.mtbio.2024.101106↗
10. Aiguo Wu · 1 shared paper, 2024 · strength 0.19
    • Paper VISTA antibody-loaded Fe3O4@TiO2 nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancrea… DOI 10.1016/j.mtbio.2024.101106↗
11. Xu Liu · 1 shared paper, 2024 · strength 0.19
    • Paper Black TiO2-based nanoparticles as Toll-like receptor stimulator delivery system for enhanced photothermal-immunotherapy… DOI 10.1186/s12645-024-00266-2↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.